Back to Amova Asset Management Americas, Inc.

CRSP
Showing 8 of 29 quarters

Position history for Amova Asset Management Americas, Inc.'s holdings in CRISPR THERAPEUTICS AG

Amova Asset Management Americas, Inc. holds 1.9M shares of CRSP (CRISPR THERAPEUTICS AG), worth $88.2M as of 2026-Q1. The position was decreased (-5.3% shares). CRSP represents 1.2% of Amova Asset Management Americas, Inc.'s portfolio.

Current Value

$88.2M

Current Shares

1.9M

Total Value Change

-$81.8M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.9M
-5.3%
$88.2M1.2%$58.06
0
2025-Q4
Decreased
2M
-9.5%
$102.6M1.2%$53.19
0
2025-Q3
Decreased
2.2M
-10.4%
$140.2M1.4%$63.77
0
2025-Q2
Decreased
2.4M
-5.0%
$117.4M1.2%$47.49
0
2025-Q1
Decreased
2.5M
-7.5%
$86.3M1.1%$36.99
0
2024-Q4
Decreased
2.7M
-7.5%
$108.1M1.2%$38.65
0
2024-Q3
Decreased
3M
-5.8%
$139.4M1.6%$47.32
0
2024-Q2
Decreased
3.2M
-3.6%
$170M2.0%$54.01
0

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used